Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

800 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
Pfaffendorf C, Vonthein R, Krockenberger-Ziegler K, Dellas K, Schreiber A, Uhlemann D, Dinges S, Würschmidt F, Andreas P, Weinstrauch E, Eilf K, Rades D, Höller U, Combs SE, Kazmierczak R, Fehlauer F, Schreck U, Zimmer J, Dunst J, Krug D. Pfaffendorf C, et al. Among authors: zimmer j. Breast. 2022 Aug;64:136-142. doi: 10.1016/j.breast.2022.05.008. Epub 2022 Jun 2. Breast. 2022. PMID: 35691249 Free PMC article. Clinical Trial.
Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phase II trial (ARO-2010-01).
Dellas K, Vonthein R, Zimmer J, Dinges S, Boicev AD, Andreas P, Fischer D, Winkler C, Ziegler A, Dunst J; ARO Study Group. Dellas K, et al. Among authors: zimmer j. Strahlenther Onkol. 2014 Jul;190(7):646-53. doi: 10.1007/s00066-014-0658-5. Epub 2014 Apr 16. Strahlenther Onkol. 2014. PMID: 24737540 Clinical Trial.
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D, Baumann R, Krockenberger K, Vonthein R, Schreiber A, Boicev A, Würschmidt F, Weinstrauch E, Eilf K, Andreas P, Höller U, Dinges S, Piefel K, Zimmer J, Dellas K, Dunst J. Krug D, et al. Among authors: zimmer j. Strahlenther Onkol. 2021 Jan;197(1):48-55. doi: 10.1007/s00066-020-01689-7. Epub 2020 Oct 1. Strahlenther Onkol. 2021. PMID: 33001241 Free PMC article. Clinical Trial.
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial.
Krug D, Vonthein R, Schreiber A, Boicev AD, Zimmer J, Laubach R, Weidner N, Dinges S, Hipp M, Schneider R, Weinstrauch E, Martin T, Hörner-Rieber J, Olbrich D, Illen A, Heßler N, König IR, Dellas K, Dunst J. Krug D, et al. Among authors: zimmer j. Strahlenther Onkol. 2021 Sep;197(9):802-811. doi: 10.1007/s00066-020-01730-9. Epub 2020 Dec 15. Strahlenther Onkol. 2021. PMID: 33320286 Free PMC article. Clinical Trial.
16th GCC Closed Forum: ICH M10 implementation; NGS, qPCR/dPCR, flow cytometry validation; tissue biomarkers; IS response; immunogenicity harmonization; bioanalytical industry status.
Zimmer J, Hays A, Lester T, Diaz M, Thomas E, O'Dell M, Hyer E, Tangri S, Dakappagari N, Yuan M, Lavelle A, Karnik S, Liu A, Xu B, Sales K, Gorityala S, Reynolds G, Sangster T, Franckaert D, Love I, Patel V, Roberge M, Lin J, Jerks E, Xu T, Garofolo W, Nadarajah S, Kernstock R, Dufield D, Ambrose D, Warrino D, Luna M, Marco CD, Tudoroniu A, Iordachescu A, Sanghvi M, Barton H, Brown M, Hoffpauir B, Rocha A, Dong K, Yamashita J. Zimmer J, et al. Bioanalysis. 2024 Jun 12:1-13. doi: 10.1080/17576180.2024.2342691. Online ahead of print. Bioanalysis. 2024. PMID: 38864397
Severely compromised supply of patch test allergens in Europe hampers adequate diagnosis of occupational and non-occupational contact allergy. A European Society of Contact Dermatitis (ESCD), European Academy of Allergy and Clinical Immunology (EAACI), European Academy of Dermatology and Venereology (EADV) task forces 'Contact Dermatitis' and 'Occupational Skin Disease' position paper.
John SM, Bonertz A, Zimmer J, Aerts O, Bauer A, Bova M, Brans R, Del Giacco S, Dickel H, Corazza M, Crépy MN, Gallo R, Garcia-Abujeta JL, Giménez-Arnau AM, Klimek L, Lepoittevin JP, Ljubojević Hadžavdić S, Matura M, Mortz CG, Özkaya E, Pesonen M, Raison-Peyron N, Rustemeyer T, Skudlik C, Spiewak R, Stingeni L, Suomela S, Symanzik C, Taylor J, Torres M, Uter W, White I, Wilkinson M, Mahler V, Johansen JD. John SM, et al. Among authors: zimmer j. Contact Dermatitis. 2024 May 29. doi: 10.1111/cod.14580. Online ahead of print. Contact Dermatitis. 2024. PMID: 38812248
Adoptive T Regulatory Cell Therapy Takes an Important Step.
Seguin-Devaux C, Zimmer J. Seguin-Devaux C, et al. Among authors: zimmer j. NEJM Evid. 2024 Jun;3(6):EVIDe2400109. doi: 10.1056/EVIDe2400109. Epub 2024 May 28. NEJM Evid. 2024. PMID: 38804780 No abstract available.
800 results